InterCure Sues Better Over Funds Deployed During Failed Merger

The loans look to be over $9 million.

InterCure Ltd. (Nasdaq: INCR), also known as Canndoc, filed a lawsuit against Cann Pharmaceuticals Ltd., also known as Better, to recover some of the money that was loaned to and invested in the company when the two contemplated a merger.

In the company’s earnings filing in November, a footnote stated in its “Other Receivables” section that the balance included “an amount of approximately NIS 34 million loaned to third parties in connection with potential acquisitions which have not yet been materialized.” Using today’s currency conversion, that is roughly $9.6 million.

During the merger process, InterCure said it extended loans to Better and provided funding and cultivation services to it, in light of the parties’ cooperation. However, the merger didn’t go as planned, and the agreement was terminated.

InterCure said it has tried to recover the money but that Better has refused to pay the money back.

The company announced the acquisition was in trouble in November 2022 and cited fundamental disagreements between the parties. InterCure also said that the closing conditions contained in the agreement were not met, and the agreement was terminated.

InterCure also said at the time that it was owed significant amounts loaned and advanced to Better.

InterCure reported in November that it had revenue of $39 million (NIS 101 million), which represented 63% growth from the third quarter of 2021 and represented sequential growth of 6%. It was the 11th consecutive quarter of growth, representing an annualized run rate of over $155 million (more than NIS 402 million).

The company also said that its revenue growth was expected to continue in the fourth quarter of 2022.

At the time it also said that it was the first company to comply with the new strict 109 import regulations of the Israel Medical Cannabis Agency, resuming the importation of medical cannabis to Israel.

Debra Borchardt

Debra Borchardt is the Co-Founder, and Executive Editor of GMR. She has covered the cannabis industry for several years at Forbes, Seeking Alpha and TheStreet. Prior to becoming a financial journalist, Debra was a Vice President at Bear Stearns where she held a Series 7 and Registered Investment Advisor license. Debra has a Master's degree in Business Journalism from New York University.

Leave a Reply

Your email address will not be published. Required fields are marked *

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.

 Sign up

About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


Recent Tweets

Back to Top

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.